Bukkems, Laura H ;
Heijdra, Jessica M ;
de Jager, Nico C.B...
OPTI-CLOT study group , Bukkems , L H , Heijdra , J M , de Jager , N C B , Hazendonk , H C A M , Fijnvandraat , K , Meijer , K , Eikenboom , J C J , Laros-Van Gorkom , B A P , Leebeek , F W G , Cnossen , M H , Mathôt , R A A , Coppens , K F M , Kruip , M J H A , Polinder , S , Lock , J , Hazendonk , H C A M , van Moort , I , Heijdra , J M , Goedhart , M C H J , Al Arashi , W , Preijers , T , Cloesmeijer , M E , Janssen , A , Tamminga , R Y J , Brons , P , Schols , S E M , Schutgens , R E G , Fischer , K , van Galen , K P M , Beckers , E A M , Heubel-Moenen , F C J I , Nieuwenhuizen , L , Ypma , P , Driessens , M H E , Zwaan , M , van Vliet , I , Collins , P W , Liesner , R , Chowdary , P , Millar , C M , Hart , D & Keeling , D 2021 , ' Population pharmacokinetics of the von Willebrand factor-factor VIII interaction in patients with von Willebrand disease ' , Blood advances , vol. 5 , no. 5 . https://doi.org/10.1182/BLOODADVANCES.2020003891.
,
2021
